A possible effect of amisulpride on a prolactinoma growth in a woman with borderline personality disorder

Pharmacol Res. 2004 Sep;50(3):377-9. doi: 10.1016/j.phrs.2004.02.010.

Abstract

The authors report the case of a woman with borderline personality disorder who developed a prolactinoma probably induced by amisulpride. This patient was treated with 300 mg of amisulpride per day for a delirium. Her brain MRI was normal. Four months later this patient developed a micro-adenoma (5mm) on the right side of the pituitary gland with amenorrhea and galactorrhea. Amisulpride treatment was withdrawn and replaced by a treatment of quetiapine 100 mg day(-1). The hyperprolactinemia symptoms disappeared. This report shows that the short-term use of amisulpride treatment was linked to an elevation in the PRL level with a possible induction of a pituitary adenoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amisulpride
  • Borderline Personality Disorder / blood
  • Borderline Personality Disorder / drug therapy*
  • Female
  • Humans
  • Pituitary Neoplasms / blood
  • Pituitary Neoplasms / chemically induced*
  • Prolactin / blood
  • Prolactinoma / blood
  • Prolactinoma / chemically induced*
  • Sulpiride / adverse effects*
  • Sulpiride / analogs & derivatives*

Substances

  • Sulpiride
  • Amisulpride
  • Prolactin